ADAM10 and acute lymphoblastic leukemia: At higher doses (490 μM), pharmacological inhibition of ADAM10 by GI254023X increased the percentage of apoptotic and dead cells in both ALL PDX samples tested to a similar degree as observed in ADAM10 KO cells (Figs. 5L and S15C, D).